These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 21884755)

  • 1. The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.
    Surmeier DJ; Guzman JN; Sanchez-Padilla J; Schumacker PT
    Neuroscience; 2011 Dec; 198():221-31. PubMed ID: 21884755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease.
    Surmeier DJ; Guzman JN; Sanchez-Padilla J
    Cell Calcium; 2010 Feb; 47(2):175-82. PubMed ID: 20053445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium homeostasis, selective vulnerability and Parkinson's disease.
    Chan CS; Gertler TS; Surmeier DJ
    Trends Neurosci; 2009 May; 32(5):249-56. PubMed ID: 19307031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons.
    Graves SM; Schwarzschild SE; Tai RA; Chen Y; Surmeier DJ
    Neurobiol Dis; 2021 Aug; 156():105409. PubMed ID: 34082123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What causes the death of dopaminergic neurons in Parkinson's disease?
    Surmeier DJ; Guzman JN; Sanchez-Padilla J; Goldberg JA
    Prog Brain Res; 2010; 183():59-77. PubMed ID: 20696315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium entry and α-synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neurons.
    Dryanovski DI; Guzman JN; Xie Z; Galteri DJ; Volpicelli-Daley LA; Lee VM; Miller RJ; Schumacker PT; Surmeier DJ
    J Neurosci; 2013 Jun; 33(24):10154-64. PubMed ID: 23761910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1.
    Guzman JN; Sanchez-Padilla J; Wokosin D; Kondapalli J; Ilijic E; Schumacker PT; Surmeier DJ
    Nature; 2010 Dec; 468(7324):696-700. PubMed ID: 21068725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The origins of oxidant stress in Parkinson's disease and therapeutic strategies.
    Surmeier DJ; Guzman JN; Sanchez-Padilla J; Goldberg JA
    Antioxid Redox Signal; 2011 Apr; 14(7):1289-301. PubMed ID: 20712409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson's disease.
    Chan CS; Gertler TS; Surmeier DJ
    Mov Disord; 2010; 25 Suppl 1():S63-70. PubMed ID: 20187241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower Affinity of Isradipine for L-Type Ca
    Ortner NJ; Bock G; Dougalis A; Kharitonova M; Duda J; Hess S; Tuluc P; Pomberger T; Stefanova N; Pitterl F; Ciossek T; Oberacher H; Draheim HJ; Kloppenburg P; Liss B; Striessnig J
    J Neurosci; 2017 Jul; 37(28):6761-6777. PubMed ID: 28592699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
    Duda J; Pötschke C; Liss B
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease.
    Surmeier DJ; Halliday GM; Simuni T
    Exp Neurol; 2017 Dec; 298(Pt B):202-209. PubMed ID: 28780195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium and Parkinson's disease.
    Surmeier DJ; Schumacker PT; Guzman JD; Ilijic E; Yang B; Zampese E
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1013-1019. PubMed ID: 27590583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's Disease: Cells Succumbing to Lifelong Dopamine-Related Oxidative Stress and Other Bioenergetic Challenges.
    Watanabe H; Dijkstra JM; Nagatsu T
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of dopaminergic neuron loss in Parkinson's disease.
    Surmeier DJ
    FEBS J; 2018 Oct; 285(19):3657-3668. PubMed ID: 30028088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress.
    Guzman JN; Ilijic E; Yang B; Sanchez-Padilla J; Wokosin D; Galtieri D; Kondapalli J; Schumacker PT; Surmeier DJ
    J Clin Invest; 2018 Jun; 128(6):2266-2280. PubMed ID: 29708514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial Dysfunction Combined with High Calcium Load Leads to Impaired Antioxidant Defense Underlying the Selective Loss of Nigral Dopaminergic Neurons.
    Ricke KM; Paß T; Kimoloi S; Fährmann K; Jüngst C; Schauss A; Baris OR; Aradjanski M; Trifunovic A; Eriksson Faelker TM; Bergami M; Wiesner RJ
    J Neurosci; 2020 Feb; 40(9):1975-1986. PubMed ID: 32005765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirt3 protects dopaminergic neurons from mitochondrial oxidative stress.
    Shi H; Deng HX; Gius D; Schumacker PT; Surmeier DJ; Ma YC
    Hum Mol Genet; 2017 May; 26(10):1915-1926. PubMed ID: 28369333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective neuronal vulnerability in Parkinson's disease.
    Gonzalez-Rodriguez P; Zampese E; Surmeier DJ
    Prog Brain Res; 2020; 252():61-89. PubMed ID: 32247375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.